Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA

Archive for the ‘Mourning the Loss of a Scientific Leader’ Category

In Memoriam: Nobel Laureate J. Michael Bishop for discovery of Retroviral Oncogenes

Posted in CANCER BIOLOGY & Innovations in Cancer Therapy, cancer-general, Mourning the Loss of a Scientific Leader, Nobel Prize Winners, Oncolytic virus & OncoViro-Therapy, tagged NIH, nobel leureates, oncogenes, Peyton Rous, Src family kinases, UCSF Medical Center, viral oncogenesis on July 31, 2026| Leave a Comment »

In Memoriam: Nobel Laureate J. Michael Bishop for discovery of Retroviral Oncogenes

Reporter: Stephen J. Williams, Ph.D.

Among the many cancer researchers who have passed this year (listed in a post here), Dr. Bishop, who won the Nobel Prize with Harold Varmus for their discovery of retroviral oncogenes deserves special mention.  Since Peyton Raus noticed that an infective agent could transfer oncogenic stimulus for formation of new sarcomas in chickens injected with a fractioned tumor lysate, the search for the molecular basis a viral elements could induce tumorigenesis had remained elusive for most of the 20th century.  From medieval times cancer had been thought to have some infective component (and people used to think that tumors themselves were able to infect others).  The identification that a virus could induce tumors in animals was a revolutionary discovery and many investigators had tried to uncover human viruses which could induce tumors as well for a large part of the 20th century.

 

Drs. Bishop and Varmuses work to determine the human homologue to the chicken virus led to a revolutionary discovery of how growth factor signaling and their proliferative effects could be explained on the molecular level and how such proteins, when mutated, could lead to abnormal proliferation and growth.

From the AACR

Source: https://www.aacr.org/professionals/membership/in-memoriam/j-michael-bishop/

In Memoriam: J. Michael Bishop

(02/22/1936 – 03/20/2026) Member since 1998

J. Michael Bishop, MD, a Fellow of the AACR Academy who shared the Nobel Prize for Physiology or Medicine in 1989 with Harold E. Varmus, MD, for their discovery of the cellular origin of retroviral oncogenes, died March 20, 2026, at the age of 90.

Bishop served as chancellor of the University of California, San Francisco, from 1998 until he retired in 2009. He presided over a major expansion of UCSF, a university that is devoted entirely to biomedical sciences.

Born in York, Pennsylvania, in 1936, Bishop grew up in a rural area and attended elementary school in a two-room schoolhouse. He received a bachelor’s degree in chemistry from Gettysburg College in 1958 and a medical degree from Harvard Medical School in 1962.

After a residency at Massachusetts General Hospital and research at the National Institute of Allergy and Infectious Diseases in Bethesda, Maryland, and the Heinrich Pette Institute in Hamburg, Germany, he joined the faculty of UCSF as assistant professor of microbiology and immunology in 1968. He became a full professor in 1972, and in 1981 he was named director of the university’s George F. Hooper Research Foundation.

In 1970, Varmus joined Bishop’s lab as a postdoctoral fellow. They began studying the Rous sarcoma virus to test the theory that healthy body cells contain dormant viral oncogenes that cause cancer when triggered. Bishop and Varmus discovered that the viral genes that cause cancer in humans and animals do not originate within viruses, as previously thought, but instead begin as normal genes within healthy cells that act to control cellular growth and division. This finding indicated that these benign genes (called proto-oncogenes) can be picked up by certain viruses and then transformed into oncogenes.

This discovery that cancer could be caused by the malfunction of normal genes revolutionized the understanding of tumorigenesis and greatly expanded the scope of associated scientific areas such as cancer detection as well as drug discovery and development.

In addition to receiving the Nobel Prize, Bishop’s honors included election to the National Academy of Sciences in 1980 and as an Honorary Fellow of the American Association for the Advancement of Science in 1987, and as a Foreign Member of the Royal Society. He received the Albert Lasker Award for Basic Medical Research in 1982, the Gairdner Foundation International Award and the Alfred P. Sloan, Jr., Prize from the General Motors Cancer Research Foundation in 1984, and the Dickson Prize in Medicine in 1986. He was presented with the 2003 National Medal of Science by President George W. Bush. He was a member of the inaugural class of Fellows of the AACR Academy in 2013.

 

Share this:

• X
• LinkedIn
• Facebook
• Print
• Email

Like this:

Like Loading…

Read Full Post »

In Memoriam: In Remembrance of Cancer Researchers who passed in 2026

Posted in Cancer Prevention: Research & Programs, Drug Discovery Chemistry, Gene Regulation, Li-fraumeni syndrome., Mourning the Loss of a Scientific Leader, Patents, TP53 - Germline mutations, tagged AACR, breast cancer, cancer risk, Li-fraumeni syndrome., novartis, nuclear receptors, Purdue University, retinol binding protein, steroid receptor, TP53 on July 13, 2026| Leave a Comment »

In Memoriam: In Remembrance of Cancer Researchers who passed in 2026

Reporter: Stephen J. Williams, Ph.D.

Source: https://www.aacr.org/professionals/membership/in-memoriam/

The following remembrances of American Association of Cancer Research (AACR) prominent member who have recently passed in 2026 is given below.  Each have contributed seminal research and discovery in the field of cancer biology and cancer risk.  In many cases, their discoveries transformed the way  we understand and treat cancer.  A separate In Memoriam for Nobel Leaureatte Dr. J. Michael Bishop will be given in a separate post.

Joseph F. Fraumeni, Jr., MD, FAACR (04/01/1933 – 06/22/2026)

Joseph F. Fraumeni, Jr., MD, FAACR, a renowned cancer epidemiologist, a Fellow of the AACR Academy, and a former member of the AACR Board of Directors, died June 22, 2026, at the age of 93. A career researcher and leader at the National Cancer Institute, Fraumeni was a co-discoverer of the genetic condition now known as the Li-Fraumeni syndrome and launched the U.S. Atlas of Cancer Mortality, which mapped geographic variations in cancer.Born April 1, 1933, in Boston, Fraumeni earned a bachelor’s degree from Harvard College, a medical degree from Duke University School of Medicine, and a master of science in epidemiology from the Harvard University School of Public Health. He completed medical residencies at Johns Hopkins Hospital and the Memorial Sloan-Kettering Cancer Center. A member of the AACR since 1968, Fraumeni served on the AACR’s Board of Directors from 1983 to 1986. He also served the AACR as an assistant editor, senior editor, and editorial board member for Cancer Epidemiology, Biomarkers & Prevention and an assistant editor for Cancer Research. The AACR recognized him with the AACR-American Cancer Society Award for Research Excellence in Epidemiology and Prevention in 1993 and the AACR Award for Lifetime Achievement in Cancer Research in 2009. He was inducted as a member of the inaugural class of Fellows of the AACR Academy in 2013. Fraumeni was a fellow of the American College of Physicians, the American Association for the Advancement of Science, and the American Academy of Arts and Sciences, and a member of the Institute of Medicine, the Association of American Physicians, and the National Academy of Sciences.

In 1962, Fraumeni joined the Epidemiology Branch of the National Cancer Institute (NCI) as a commissioned officer in the U.S. Public Health Service (USPHS). He went on to hold several leadership positions at the NCI, including posts as head of the Ecology Studies Section, chief of the Environmental Epidemiology Branch, director of the Epidemiology and Biostatistics Program, and founding director of the Division of Cancer Epidemiology and GeneticsHe retired from the USPHS in 1999 with the rank of rear admiral and assistant surgeon general. When he retired from NCI in 2017, he was named Scientist Emeritus. He authored or co-authored more than 900 scientific publications.

His research focused the epidemiology of high cancer risk populations and, in 1969, led him to discover a familial syndrome of early-onset cancers of the breast, brain, and other malignancies known as Li-Fraumeni Syndrome.  Li-Fraumeni Sydrome is characterized by inherited mutations in the p53 tumor suppressor gene.

Li-Fraumeni Syndrome

from Cleveland Clinic: Li-Fraumeni syndrome is a rare genetic disorder that increases the risk you and your family members will develop cancer. Everyone with this condition has a 90% chance of developing one or more types of cancer by age 60. About half develop cancer before they turn 40. Females with Li-Fraumeni syndrome almost always develop breast cancer.

Below is the original reference published with his colleague the late Dr, Federick Li.  Thier work together over the years helped develop the discovery of cancer susceptiblitiy genes and the importance of mutations of these genes linked to increased risk of developing cancer.

Li FP, Fraumeni JF Jr. 1969. Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med 71: 747–752.

Four families were identified in which a pair of children had soft-tissue sarcomas: three sets of sibs and one set of cousins. One parent of each affected child developed cancer; carcinoma of the breast occurred in three mothers under 30 years of age. Other young adults in these families had a high frequency of cancer, with no evidence of underlying genetic disorders known to carry a high risk of neoplasia. The increased familial susceptibility to cancer was manifested not only by the large number of members affected but by a seeming excess of multiple primary neoplasms.

It wasn’t until the 1990’s that Malkin et al. that germline mutations in TP53 were associated with this disease

Malkin D, Li FP, Strong LC, Fraumeni JF Jr, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA, et al. 1990. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250: 1233–1238.

A similar syndrome named Lynch syndrome also  gave rise to early increased risk of multiple cancers but due to germline mutations in mismatch repair genes like MLH1, MSH2, MSH6, or PMS2.

Lynch HT, Mulcahy GM, Harris RE, Guirgis HA, Lynch JF. 1978. Genetic and pathologic findings in a kindred with hereditary sarcoma, breast cancer, brain tumors, leukemia, lung, laryngeal, and adrenal cortical carcinoma. Cancer 41: 2055–2064.

 

Pierre Chambon, MD, FAACR, (02/07/1931 – 05/05/2026)

Pierre Chambon, MD, FAACR, a Fellow of the AACR Academy who was a pioneer in the structure and expression of genes, died May 5, 2026, at the age of 95. Chambon’s early work contributed to the discovery of PolyADPribose, the discovery of multiple RNA polymerases, major contributions to the elucidation of chromatin structure, and the discovery of animal split genes. Later work included the discovery of multiple promoter elements and their cognate factors. His research on nuclear receptors has had a marked influence on the understanding of signal transduction and endocrinology in vertebrates.

Born February 7, 1931, in Mulhouse, France, Chambon received his medical degree from the University of Strasbourg in 1958. He joined the university as a research associate, becoming an associate professor in 1962 and professor of biochemistry in 1968. He founded the Institute for Genetics and Cellular and Molecular Biology in 1994 and served as its director until 2002. He then founded the Mouse Clinical Institute and served as director until 2006. He held the chair of molecular genetics at the Collège de France from 1993 to 2003 and served as chair of molecular genetics and biology at the University of Strasbourg Institute for Advanced Study from 2012 to 2021. Chambon was elected to the French Academy of Sciences in1985, the same year in which he was elected a foreign member of both the U.S. National Academy of Sciences and the American Academy of Arts and Sciences.

Juliet M. Daniel, PhD

Juliet M. Daniel, PhD, a cell biologist who was a distinguished university professor at McMaster University in Hamilton, Ontario, and member of AACR since 2002, died April 28, 2026. She was 61 years of age. Noted for her work on genetic risk factors for breast cancer, Daniel discovered and gave the name “Kaiso” to a gene associated with triple negative breast cancer in women of African descent. Born in Barbados in 1964, Daniel obtained a bachelor’s degree in life sciences from Queen’s University in Kingston, Ontario, in 1987 and a doctorate in microbiology from University of British Columbia in Vancouver in 1993. She conducted postdoctoral research at St. Jude Children’s Research Hospital in Memphis and Vanderbilt University in Nashville. She joined McMaster as an assistant professor in 1999, the first black woman to become a member of the Faculty of Science. She was promoted to associate professor in 2005 and professor in 2012. Daniel was appointed associate dean of research and external relations for the Faculty of Science on an acting basis in 2020 and permanently in 2021. She was named strategic advisor to the university president for the Canada-Caribbean Institute (CCI) at McMaster in 2024. She was named a distinguished university professor, the highest faculty honor, in 2025. Among many other honors, she was elected a fellow of the Canadian Academy of Health Sciences in 2025, received the inaugural Canadian Cancer Society Inclusive Excellence Prize in Cancer Research in 2020, and was awarded an honorary doctorate in science by the University of the West Indies in 2021.

Philip S. Low, PhD

Philip S. Low, PhD, the Ralph C. Corley distinguished professor of chemistry at Purdue University, an inventor and entrepreneur with more than 100 patents to his credit, and an emeritus member of AACR, died March 4, 2026, at the age of 78. He also served as Purdue’s Presidential Scholar for Drug Discovery and was for a time as director of the university’s Center for Drug Discovery. Low held more than 100 U.S.-issued patents through Purdue Innovates and is listed on 600 U.S. and international patents and 145 invention disclosures. He founded seven companies based on based on work conducted at Purdue, one of which, Endocyte Inc., was sold to Novartis in 2018. Born in Ames, Iowa, in 1947, Low earned a bachelor’s degree in chemistry from Brigham Young University in 1971 and a doctorate in biochemistry from the University of California, San Diego, in 1975. He joined the Purdue University faculty in 1976. An AACR member since 2005, Low received the AACR Award for Outstanding Achievement in Chemistry in Cancer Research in 2015 in recognition of his research on low molecular weight ligand-targeted therapeutic and imaging agents. In the same year, he also received the American Chemical Society (ACS) George & Christine Sosnovsky Award for Cancer Research and was elected to the National Academy of Inventors. In August 2025, Low was named the recipient of the ACS Alfred Burger Award in Medicinal Chemistry for 2026. He also received the Order of the Griffin and the Morrill Award from Purdue.

For more remebrances of past AACR members please visit: https://www.aacr.org/professionals/membership/in-memoriam/

Other recent In Memoriam on this Open Access Scientific Journal Include:

News from AACR; In Memoriam: Nobel Leaureate David Baltimore, Ph.D

In Memoriam: Professor Yitzhak Apeloig, President and Distinguised Professor of the Technion

 

 

 

Share this:

• X
• LinkedIn
• Facebook
• Print
• Email

Like this:

Like Loading…

Read Full Post »

In Memoriam: Professor Yitzhak Apeloig, President and Distinguised Professor of the Technion

Posted in Drug Delivery Platform Technology, Drug Discovery Chemistry, Mourning the Loss of a Scientific Leader, tagged computational chemistry, Israel Chemical Society Gold Medal, Memoriam, silicon chemistry, Technion, The ACS Frederic Stanley Kipping Award in Silicon Chemistry, The Schrödinger Medal, The Wacker Silicone Award on June 4, 2026| Leave a Comment »

In Memoriam: Professor Yitzhak Apeloig, President and Distinguised Professor of the Technion

Reporters: Aviva Lev-Ari, PhD, RN and Stephen J. Williams, Ph.D.

From the Technion:

The Technion community mourns the passing of Distinguished Professor Yitzhak Apeloig (1944–2026), president of the Technion from 2001 to 2009 and one of Israel’s most distinguished chemists.
A pioneer in computational chemistry and organosilicon compounds, Prof. Apeloig made groundbreaking scientific contributions while mentoring generations of researchers and helping position the Technion as a global leader in science and technology.
During his presidency, he expanded interdisciplinary research, strengthened international partnerships, increased investment in research infrastructure and scholarships, and advanced collaboration between engineering, medicine, and the humanities.“Prof. Apeloig led the Technion with quiet confidence and steadfast leadership,” said Technion President Prof. Uri Sivan. “His years in office were marked by exceptional academic development and a profound impact on the State of Israel and beyond.”
The Technion was his home and family. He will be deeply missed. May his memory be a blessing.

Activate to view larger image,

Distinguished Professor Yitzhak Apeloig (1944–2026), president of the Technion from 2001 to 2009 and one of Israel’s most distinguished chemists

A brief synopsis of Dr. Apeloig’s scientific achievements and contributions toward the field of chemistry:

1. Pioneering Computational Quantum Chemistry

In the 1970s, Apeloig was one of the first experimental chemists in the world to recognize the immense potential of using quantum theory and computational models to predict molecular characteristics.

• The “First Calculate, Then Synthesize” Philosophy: He pioneered a paradigm shift in organic chemistry by using quantum-mechanical calculations to predict whether a novel molecule could exist and what its lifespan would be before attempting physical synthesis in the laboratory.
• He was unique for his time in requiring his students to master both computational modeling and physical laboratory experimentation rather than separating the disciplines.

2. Breakthroughs in Organosilicon Chemistry

Before Apeloig’s work, much of the scientific community believed that silicon could not easily form stable multiple bonds (such as $Si=Si$ or $Si=C$ double bonds) in the way carbon does. Apeloig revolutionized the field of organosilicon chemistry:

• Low-Coordination Silicon Compounds: He successfully used computational tools combined with experimental testing to predict, isolate, and understand highly reactive, low-coordination silicon species. This included landmark research into multiply-bonded silicon compounds, silyl radicals, silyl anions, silylenes, and metallosilane reagents.
• Silicone and Materials Science: His structural insights fundamentally advanced the molecular understanding of silicon polymers and siloxanes, which heavily influenced the development of advanced moulding materials, rubbers, and photosensitive materials used in lithography.

3. Discovery of Reactive Intermediates

During his early career and PhD research, he focused heavily on physical organic chemistry and organic reaction mechanisms:

• He was the first to experimentally demonstrate that a vinyl cation holds a linear geometry around its carbocationic center.
• His extensive work mapping out short-lived, highly reactive intermediates (like carbenium ions and strained molecules) provided the foundational mechanics for how complex organic reactions occur.

Major Recognitions

For these definitive contributions to computational and silicon chemistry, Apeloig was awarded some of the highest honors in the discipline:

• The Schrödinger Medal (2021): Awarded by the World Association of Theoretical and Computational Chemists (WATOC) for his seminal contributions to theoretical chemistry.
• The ACS Frederic Stanley Kipping Award in Silicon Chemistry (2010): The premier international award recognizing advancements in the study of silicon.
• The Wacker Silicone Award (2007) and the Israel Chemical Society Gold Medal (2017).

The seminal publications that define his academic footprint include:

1. Foundational Computational and Structural Chemistry

During the mid-1970s and 1980s, Apeloig co-authored several massive, highly cited studies establishing the rules of computational molecular architecture, specifically challenging traditional rules of carbon and silicon bonding.

• “Stabilization of planar tetracoordinate carbon”
  • Journal of the American Chemical Society (1976)
  • Co-authors: J. B. Collins, J. D. Dill, E. D. Jemmis, P. v. R. Schleyer, R. Seeger, J. A. Pople
  • Impact: A true milestone in structural chemistry that theoretically demonstrated how specific substitution patterns could stabilize a planar geometry around a carbon atom, defying the standard tetrahedral configuration.
• “A theoretical survey of unsaturated or multiply bonded and divalent silicon compounds. Comparison with carbon analogs”
  • Journal of the American Chemical Society (1986)
  • Co-authors: B. T. Luke, J. A. Pople, M. B. Krogh-Jespersen, M. Karni, J. Chandrasekhar, P. v. R. Schleyer
  • Impact: A definitive ab initio survey that comprehensively mapped out the differences between carbon and silicon multiple bonds, predicting the stability and reaction behaviors of transient silicon chemical species.

2. High-Impact Silicon and Stable Carbene Analogs

In the 1990s and 2000s, Apeloig focused on predicting and identifying highly sought-after reactive intermediates—particularly “impossible” double bonds and carbenes.

• “On the Question of Stability, Conjugation, and ‘Aromaticity’ in Imidazol-2-ylidenes and Their Silicon Analogs”
  • Journal of the American Chemical Society (1996)
  • Co-authors: C. Heinemann, T. Müller, H. Schwarz
  • Impact: Heavily cited paper evaluating the electronic properties, structural stability, and aromaticity of N-heterocyclic carbenes (NHCs) versus their heavier silicon counterparts (silylenes).
• “Substituent effects on the geometries and energies of the silicon-silicon double bond”
  • Journal of the American Chemical Society (1990)
  • Co-author: M. Karni
  • Impact: This study mapped how changing the attached chemical groups altered the trans-bending and bond lengths of $Si=Si$ double bonds, establishing a predictive guide for experimentalists trying to isolate stable disilenes.

3. Definitive Academic Reviews and Reference Books

Beyond standalone journal entries, Apeloig is globally recognized for editing the foundational texts that summarized the state of organosilicon chemistry for generations of scientists.

• “The Chemistry of Organic Silicon Compounds” (Volumes 1, 2, and 3)
  • Co-edited with: Zvi Rappoport (Published by John Wiley & Sons, beginning in 1989)
  • Impact: Apeloig authored critical chapters, such as “Theoretical Aspects of Organosilicon Compounds,” within these volumes. This multi-book compendium serves as the literal “bible” for researchers studying silicon polymers, reactive silicon intermediates, and silicon-based material sciences.

Share this:

• X
• LinkedIn
• Facebook
• Print
• Email

Like this:

Like Loading…

Read Full Post »

In 2020 – 70 years a part @MIT: The Online 2020 Commencement & Presidential Address @MIT and The Online Premiere of the Shannon Documentary – The Bit Player. A Unique Tribute to Claude Shannon Screened at 2020 International Symposium on Information Theory 

Posted in Interviews with Scientific Leaders, Mourning the Loss of a Scientific Leader, Noble Prize (Not Nobel Prize) on June 29, 2020| Leave a Comment »

In 2020 – 70 years a part @MIT: The Online 2020 Commencement & Presidential Address @MIT and The Online Premiere of the Shannon Documentary – The Bit Player. A Unique Tribute to Claude Shannon Screened at 2020 International Symposium on Information Theory 

Reporter: Aviva Lev-Ari, PhD, RN

WordCloud Image Produced by Adam Tubman

The Online 2020 Commencement at MIT

WATCH VIDEO

https://www.linkedin.com/video/live/urn:li:ugcPost:6672179189057167360/

The Online premiere of the Shannon Documentary – The Bit Player. A unique tribute to Claude Shannon screened at 2020 International Symposium on Information Theory 

WATCH VIDEO – The trailer for The Bit Player on Vimeo

https://mailchi.mp/db216e63ba60/call-for-papers-ieee-jstsp-special-issue-on-data-science-37170?e=c9c19f407a

Share this:

• X
• LinkedIn
• Facebook
• Print
• Email

Like this:

Like Loading…

Read Full Post »

Mourning the Loss of NIAMS Director Stephen Katz, M.D., Ph.D. – A Leader in Immunology of Skin Diseases

Posted in Mourning the Loss of a Scientific Leader on December 22, 2018| Leave a Comment »

Francis S. Collins, M.D., Ph.D., Director, NIH mourns NIAMS Director, Stephen Katz, M.D., Ph.D.

Reporter: Aviva Lev-Ari, PhD, RN

WordCloud Image Produced by Adam Tubman

December 20, 2018

Mourning the Loss of NIAMS Director Stephen Katz, M.D., Ph.D. – A Leader in Immunology of Skin Diseases

 

 

Stephen Katz, M.D., Ph.D., Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)NIH

It is with a profoundly heavy heart that I share with you the sad news that we have lost one of our most beloved leaders at NIH. Steve Katz, M.D., Ph.D., the long-time Director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), died early this morning after suffering a catastrophic stroke. Just yesterday he was working on a presentation for this morning’s Steering Committee, and now he is gone. I am still reeling from this sudden, tragic turn of events. But I want to reflect on who Steve was and what he meant to NIH, the biomedical research enterprise, and to me personally, as a close friend.

Steve was born in New York, grew up in Bethesda, trained in internal medicine and dermatology, and came to NIH in 1974 as a Senior Investigator in the Dermatology Branch at the National Cancer Institute, initiating a highly productive research program in the immunology of skin diseases. Six years later he was Branch Chief. And when a Director for NIAMS was sought in 1995, it was Steve who emerged as the ideal candidate. Over these years he has ably led an Institute that has made major contributions to research across a broad portfolio of disorders that affect millions of Americans. As just one example, it has been my personal privilege to work closely with him on the Accelerated Medicines Partnership (AMP) project that is shedding dramatic new light on the pathogenesis of rheumatoid arthritis and lupus. Steve was also a remarkable nurturer of his staff, always striving to give them the credit for progress.

But I would claim that there is no Institute Director who has done more over the last two decades to help the entire NIH enterprise flourish. When Harold Varmus, Elias Zerhouni, Raynard Kington, Larry Tabak, or I needed someone to wrestle a difficult budget issue to the ground, we called Steve. When we needed someone to provide wise advice on a complex topic (most recently, Big Data), we called Steve. When we wanted someone to mentor to new member of NIH leadership, we called Steve. And he always said yes. His legacy is simply profound.

I am also fortunate to claim Steve as a friend. It was a gift to be in his orbit of wisdom, warmth, and humor. It was a joy to see how he immediately fell in love with a grandchild just a month ago. He was also a fellow musician, and he taught me a song that is now a favorite. There is a verse of this song (B’Shana Ha’ba’a) for which the words now seem particularly appropriate. Here they are in English, though Steve also taught me the Hebrew version:

Men have dreams, men have died
To make a bright tomorrow,
And their vision remains in our hearts.
Now the torch must be passed
With hope and not in sorrow,
And a promise to make a new start.

The torch has been passed. May we strive to live up to the example of dedication and wisdom set by our dear friend Steve, even as we convey our deep condolences to his wife Linda and his children.

With sorrow for our shared loss, but gratitude for Steve’s many gifts to us,

Francis S. Collins, M.D., Ph.D.
Director

SOURCE

https://www.nih.gov/about-nih/who-we-are/nih-director/statements/mourning-loss-niams-director-stephen-katz-md-phd

Share this:

• X
• LinkedIn
• Facebook
• Print
• Email

Like this:

Like Loading…

Read Full Post »

• Follow Blog via Email

  Enter your email address to follow this blog and receive notifications of new posts by email.

  Email Address

  Follow

  Join 2,041 other subscribers

• Recent Posts

  • In Memoriam: Nobel Laureate J. Michael Bishop for discovery of Retroviral Oncogenes July 31, 2026
  • Companies Actively Engaging Artificial Intellegence for Drug Design: 2026 July 31, 2026
  • AI-Native Drug Discovery Landscape 2026 – How LPBI Group Differentiates in the New Era of Foundation Models July 19, 2026
  • In Memoriam: In Remembrance of Cancer Researchers who passed in 2026 July 13, 2026
  • Urgent Request for Action on Proposed Rule Affecting Federal Funding Grant Review July 7, 2026
  • 2026 Tang Prize in Biopharmaceutical Science Awarded to Three Pioneers of Cellular Immunotherapy Revolutionizing Treatments for Blood Cancers and Solid Tumors July 5, 2026
  • Protected: KOL on Competitive Dynamics: LPBI Group’s Founder’s Radar Screens on AI-in-Health, Life Sciences & BioPharma June 15, 2026
  • Tumor Infiltrating Lymphocytes (TIL) as a first of kind FDA approved immunotherapy for cancer June 12, 2026
  • A Systematic Analysis of Competitive Dynamics in the AI Revolution — Strategic Relevance to LPBI Group’s Mission – Alex Wissner-Gross Daily Newsletters by KOL (March 1 – June 10, 2026, to be extended to Present) June 11, 2026
  • In Memoriam: Professor Yitzhak Apeloig, President and Distinguised Professor of the Technion June 4, 2026

• Archives

  Archives Select Month July 2026  (6) June 2026  (4) May 2026  (1) January 2026  (10) December 2025  (8) November 2025  (8) October 2025  (12) September 2025  (2) July 2025  (4) June 2025  (8) May 2025  (4) April 2025  (2) March 2025  (1) February 2025  (2) January 2025  (3) December 2024  (1) November 2024  (5) October 2024  (7) September 2024  (7) August 2024  (1) June 2024  (1) May 2024  (2) April 2024  (2) January 2024  (1) November 2023  (1) October 2023  (3) September 2023  (3) August 2023  (2) July 2023  (2) June 2023  (7) May 2023  (4) April 2023  (2) March 2023  (5) February 2023  (2) January 2023  (3) December 2022  (2) October 2022  (6) September 2022  (2) August 2022  (1) July 2022  (3) June 2022  (3) May 2022  (8) April 2022  (10) March 2022  (7) February 2022  (7) January 2022  (3) December 2021  (3) November 2021  (4) October 2021  (11) September 2021  (5) August 2021  (8) July 2021  (21) June 2021  (8) May 2021  (10) April 2021  (8) March 2021  (15) February 2021  (17) January 2021  (20) December 2020  (10) November 2020  (12) October 2020  (26) September 2020  (17) August 2020  (22) July 2020  (27) June 2020  (33) May 2020  (26) April 2020  (42) March 2020  (22) February 2020  (11) January 2020  (7) December 2019  (20) November 2019  (13) October 2019  (11) September 2019  (3) August 2019  (8) July 2019  (25) June 2019  (47) May 2019  (40) April 2019  (27) March 2019  (29) February 2019  (17) January 2019  (50) December 2018  (14) November 2018  (17) October 2018  (18) September 2018  (17) August 2018  (8) July 2018  (20) June 2018  (22) May 2018  (17) April 2018  (12) March 2018  (20) February 2018  (26) January 2018  (16) December 2017  (6) November 2017  (20) October 2017  (13) September 2017  (16) August 2017  (16) July 2017  (19) June 2017  (20) May 2017  (32) April 2017  (21) March 2017  (10) February 2017  (24) January 2017  (21) December 2016  (43) November 2016  (8) October 2016  (40) September 2016  (67) August 2016  (59) July 2016  (75) June 2016  (37) May 2016  (95) April 2016  (152) March 2016  (175) February 2016  (196) January 2016  (139) December 2015  (90) November 2015  (287) October 2015  (237) September 2015  (115) August 2015  (96) July 2015  (63) June 2015  (44) May 2015  (53) April 2015  (76) March 2015  (95) February 2015  (83) January 2015  (75) December 2014  (75) November 2014  (88) October 2014  (135) September 2014  (117) August 2014  (88) July 2014  (88) June 2014  (109) May 2014  (60) April 2014  (85) March 2014  (58) February 2014  (72) January 2014  (107) December 2013  (104) November 2013  (136) October 2013  (62) September 2013  (32) August 2013  (46) July 2013  (74) June 2013  (110) May 2013  (112) April 2013  (86) March 2013  (92) February 2013  (63) January 2013  (63) December 2012  (46) November 2012  (71) October 2012  (84) September 2012  (82) August 2012  (122) July 2012  (59) June 2012  (34) May 2012  (46) April 2012  (2)

• Categories

  Categories Select Category 3D Printing for Medical Application  (239)    3D Plotting Scaffolds  (44)    BioInks  (34)       Biopolymer Blend Open Porous  (18)       Dental Applications  (10)    BioPrinting in Regenerative Medicine  (77)       Cell Level  (16)       MicroEngineering Cell-Tissue & Systems  (31)       Tissue Engineering  (37)    Cardiovascular and Vascular Systems  (30)       Artificial Vascular Structures  (9)       Cardiovascular Tissue  (8)    Drug Development using MultiOrgan Chip  (11)    Drug Development/Formulation using 3D Printing  (10)    MEMS  (16)       Bio-MEMS  (12)    Organ-on-a-Chip  (11)    Programmable Sensors (Carbon Nano Tubes)  (5) 3rd Party IP: Drug DIscovery  (1) 4D Printing and Meta Materials  (10) Academic Publishing  (223)    Key Opinion Leaders in eScientific Publishing – Interviews with  (8) Advanced Drug Manufacturing Technology  (96)    Antimalarial Preparation  (8)    Autologous Cell Therapy  (14)    Automated Cell Processing  (13) Allergy and Infectious Diseases  (12) Alzheimer’s Disease  (163)    Etiology  (77)    Medical Device Therapies for Altzheimer’s Disease  (15)    Pharmacotherapy and Cell Activity  (51) Anticancer Resistance  (31) Art Exhibits on the Human Condition  (1) Art Inspires Science  (4) Article Type  (2)    Authored  (1)    Curated  (2)    Scientific report  (1) Artificial Heart  (2) Artificial Intelligence – General  (237)    An executive’s guide to AI  (11)    Artificial Intelligence – Breakthroughs in Theories and Technologies  (118)    Artificial Intelligence Applications in Health Care  (129)       Artificial Intelligence in CANCER  (41)       Artificial Intelligence in Health Care – Tools & Innovations  (76)    Artificial Intelligence in Medicine – Application for Diagnosis  (71)       Artificial intelligence applications for cardiology  (32)          AI-assisted Cardiac MRI  (10)       Artificial Intelligence in Psychiatry  (6)       Deep Learning in Pathology  (18)    Artificial Intelligence in Medicine – Applications in Therapeutics  (69)    ChatGPT, GPT-4  (7)       ChatGPT at LPBI Group  (3)       ChatGPT in Academic Education  (3)    Machine Learning  (73)       Deep Learning  (26)       Natural Language Processing (NLP)  (45)    Machine learning in predicting type 2 diabetes  (5) Auditory and vision  (13) Autism Spectrum Disorders  (10) Autoimmune Inflammatory DIseases  (24)    Crohn’s disease  (5)    Tolerance-inducing Autoimmune Disease Therapeutics  (6)    Ulcerative Colitis  (3) Autophagosome  (4) Bacterial Resistance  (25) Behavior  (26) Behavioral Genetics  (21) Big Data  (88)    Intelligent Information Systems  (51) Bio Instrumentation in Experimental Life Sciences Research  (368)    Analytical Instruments Industry  (5)    Microfuidics  (8) Bio-Ethics  (16) BioBanking  (36) Biodegradable Drug-eluting Material  (8) Bioengineering & reverse engineering design  (43) BioIT: BioInformatics  (147) BioIT: BioInformatics, NGS, Clinical & Translational, Pharmaceutical R&D Informatics, Clinical Genomics, Cancer Informatics  (135)    Advanced Computing Platform  (32)       Blockchain Transactions System  (6)          Platform for Content Monetization embedded Content Promotion  (1)    Pancreatic adenocarcinoma classifier  (4)    Simulation Modeling in NGS  (5) Biological Engineering  (43) Biological Networks  (193) Biological Networks, Gene Regulation and Evolution  (479)    Virology  (10) Biomarkers & Medical Diagnostics  (571)    VOC – Volatile Organic Compounds as BioMarkers  (2) Biomedical Measurement Science  (173) BioSimilars  (112) BioTechnology – Venture Creation  (132)    Foundations for supporting Science and Education  (14)    Philanthropy to Academic Institution  (3) BioTechnology – Venture Creation, Venture Capital  (109)    Seeking Talent  (3) BiVAD  (1) Blindness  (6) Bone Disease and Musculoskeletal Disease  (82) Brain Basis of Emotion  (5) Business Career Consideration  (1) Ca2+ triggered activation  (61) Calcium  (21) Calcium Signaling  (71) Calmodulin Kinase and Contraction  (36) Cancer – General  (186) Cancer and Current Therapeutics  (412)    interventional oncology  (49)       Breast Cancer – impalpable breast lesions  (20)       Prostate Cancer: Monitoring vs Treatment  (9) CANCER BIOLOGY & Innovations in Cancer Therapy  (1,127)    Anaerobic Glycolysis  (51)    Cachexia  (18)    Cancer Genomics  (85)       Circulating Tumor Cells (CTC)  (27)          Liquid Biopsy Chip detects an array of metastatic cancer cell markers in blood  (17)             mRNA  (6)          MagSifter chip  (1)       KRAS Mutation  (9)       Li-fraumeni syndrome.  (4)       TP53 – Germline mutations  (9)    cancer metabolism  (28)    Funding Opportunities for Cancer Research  (13)    Genomic Expression  (150)    Glioblastoma  (7)    Hexokinase  (14)    Loss of function gene  (18)    Metabolic Immuno-Oncology  (21)    Metastasis Process  (15)    Methylation  (33)    Microbiome and Responses to Cancer Therapy  (10)    Monoclonal Immunotherapy  (29)    mtDNA  (13)    Oxidative phosphorylation  (56)    Pancreatic cancer  (10)    Pyruvate Kinase  (27)    The NCI Formulary  (1)    tumor microenvironment  (16)    Warburg effect  (50) Cancer Informatics  (104) Cancer Prevention: Research & Programs  (132) Cancer Screening  (108) Cancer Vaccines: Targeting Cancer Genes for Immunotherapy  (30)    Engineering Enhanced Cancer Vaccines  (3) cancer-general  (7) Cardiac and Cardiovascular Surgical Procedures  (328)    Aortic Valve: TAVR, TAVI vs Open Heart Surgery  (91)       Prosthesis-Patient Mismatch (PPM) in TAVI vs SAVR  (2)       TAVI vs Open Heart Surgery  (6)       Transcatheter Aortic Valve Replacement via the Transcarotid Access  (3)       Transcaval TAVR Procedure  (3)       Valve-in-Valve Procedure  (5)    Atrial Fibrilation (a-Fib), Cardiac Pacing and Arrhythmias  (18)    BackBeat’s Cardiac Neuromodulation Therapy (CNT) bioelectronic therapy  (1)    CABG  (47)    Cancer Surgery of the Heart  (10)    Cardiovascular Fluid Management: algorithms  (1)    Heart Transplant  (16)    Heart-Lung Transplant  (11)    Implantation  (3)    Left Main Coronary Artery Disease (LMCAD)  (3)    Mechanical Assist Devices: LVAD, RVAD, BiVAD, Artificial Heart  (22)    Mitral Valve: Repair and Replacement  (64)       TMVR – Transcatheter Mitral Valve Repair  (5)    PCI  (108)       Bioresorbable Vascular Scaffold (BVS)  (4)       Invasive FFR for PCI  (2)       Multivessel PCI FFR Guidance  (1)       Robotic-assisted percutaneous coronary intervention  (2)       Stent Retriever in endovascular thrombectomy  (3)    Peripheral Arterial Disease & Peripheral Vascular Surgery  (65)       Abdominal Aorta  (20)       Carotid Artery  (15)       Limb ischemia  (4)       Thoracic Aorta  (16)    Pulmonary Valve Replacement and Repair  (3)    Renal Denervation  (20)    Replacement  (1)    Robotically assisted Cardiothoracic Surgery  (2)    Tricuspid Valve Repair  (7)    Vena Caval Filters: Device for Prevention of Pulmonary Embolism and Thrombosis  (2) Cardiovascular Pharmacogenomics  (171) Cargo  (3) Cell Biology  (323) Cell Biology, Signaling & Cell Circuits  (672)    Apoptosis  (17)    Autophagy-Modulating Proteins  (6)    “Antibody–enzyme conjugates”  (6)    Cell Processing System in Cell Therapy Process Development  (27)    Endoplasmic reticulum  (3)    Enzymatic mechanism underlying the synthesis of adenosine triphosphate (ATP)  (3)    Ubiquitin  (11) Cerebrovascular and Neurodegenerative Diseases  (123)    Stroke  (9) Chemical Biology and its relations to Metabolic Disease  (464)    #BIGAxisSummit  (1)    Gut Microbiome and Obesity  (8) Chemical Genetics  (350) Child and Adolescent Psychiatry  (13) Childhood cancer  (17) Childhood malnutrition  (3) children  (3) Circulating Progenitor Cells  (27)    Bone marrow derived cells  (17)    Endothelial cells  (7)    Umbilical cord cells  (6) Clinical & Translational  (238) Clinical Diagnostics  (220)    Mass automation of plasma proteins  (13) Clinical Genomics  (144) Coagulation Therapy and Internal Bleeding  (83) Cognition  (47) Commercialization  (20) Components and IRB related issues  (4) Computational Biology/Systems and Bioinformatics  (470)    Computational Histopathology  (3)    Meta-analysis of transcriptome data  (10) Conference Coverage with Social Media  (494)    MassBio  (3) coronavirus  (18) COVID-19  (20) CRISPR/Cas9 & Gene Editing  (192)    CRISPR alternative for editing genes without cutting  (14)       CAST – Alternative to CRISPR/Cas9  (3)       Transposon-encoded CRISPR–Cas systems direct RNA-guided DNA integration  (4)    CRISPR applied to Human Germ Line  (13)       Gene Editing Impact on Longevity  (6) CT  (20) Cytokines  (21) Cytoskeleton  (85) Developmental biology  (107) Diabetes Mellitus  (146)    Artificial Pancreas for Type 2 Diabetes  (4)    Artificial Pancreas for Type1 Diabetes  (8)    Gestational diabetes  (5) Diagnostic Immunology  (61) Diagnostics and Lab Tests  (128)    Liquid Biopsy: Circulating Tumor Cells in Urine and Blood  (9) Digital HealthCare – biotech & internet joint ventures  (47) Disease Biology  (334) Disease Biology, Small Molecules in Development of Therapeutic Drugs  (488) DNA repair  (73)    Apoptosis  (13)    Autophagy  (13)    Cell death pathways  (19)    Proteolysis  (8)    Proteosome  (8) Drug Delivery Platform Technology  (159)    Drug Carrier Design  (21)       Medication Remote Compliance Monitoring  (3)    Exosomes: Natural Carriers for siRNA Delivery  (9) Drug Toxicity  (74) Ecosystems & Industrial Concentration in the Medical Device Sector  (172)    Cardiac & Vascular Repair Tools Subsegment  (128)    Exec Compensation in the Cardiac & Vascular Repair Tools Subsegment  (14)    Massachusetts Niche Suppliers and National Leaders  (20) Electronic Health Record  (10) Embryology  (24) Empathy  (6) Endocrine Diseases  (60) Enzyme Induction  (46)    ion-transporting enzyme  (2)    K + -ATPase.  (1)    Na +  (2) Epigenetics and Environmental Factors  (35) Ethics and Leadership  (10) Executive Compensation – Big Pharma  (3) Fat soluble vitamins  (4) FDA  (71) FDA Regulatory Affairs  (358)    FDA, CE Mark & Global Regulatory Affairs: process management and strategic planning – GCP, GLP, ISO 14155  (52)    ISO 10993 for Product Registration: FDA & CE Mark for Development of Medical Devices and Diagnostics  (30) Fetal Ultrasound  (2) Fiction and medicine  (5) Frontiers in Cardiology and Cardiovascular Disorders  (929)    Acute Myocardial Infarction  (63)       Cardiogenic Shock  (5)    Anemia in CVD Patients  (6)    Cardio-Oncology  (4)    Cardiomyopathy  (57)    Cardiovascular Research  (187)       Myocardial metabolism, Myocardial ischemia, myocardial perfusion, Myocardial adenine nucleotide metabolism  (64)       Pre-Clinical Animal Model Development  (23)    Chronic Thromboembolic Pulmonary Hypertension (CTEPH) and Pulmonary Arterial Hypertension (PAH)  (20)    Cost of Inpatient Stay for Cardiovascular Diagnosis for Admission  (1)    Electrophysiology  (111)       Ablation Procedure vs Drug Therapy  (2)       Arrhythmia Detection with Machine Learning Algorithms  (7)       Cardiotoxic Risks of Immune Checkpoint Inhibitors  (1)       Genomic Analysis of EKG Electrophysiology Genomics  (3)       implantable cardioverter defibrillator (ICD) and External Defibrillation  (1)       implantable pacemaker  (2)       Rare heart rhythm disorders and Long QT syndrome (LQTS)  (7)    Epigenetics and Cardiovascular Risks  (57)    Heart Failure (HF)  (51)       Acute coronary syndrome  (7)       congestive heart failure  (19)       Hypertensive Disorders of Pregnancy  (1)    Medical Devices R&D and Inventions  (212)       Assist Devices: LV  (3)       RV  (1)       Stents & Tools  (90)       Valves & Tools  (67)    Origins of Cardiovascular Disease  (422)       Atherogenic Processes & Pathology  (180)       Congenital Heart Disease  (34)          Genetic Mutations in Congenital Heart Disease  (4)       inflammation independent of lipid levels  (13)       Systemic Inflammatory Diseases as CVD Risk  (12)    Pharmacotherapy of Cardiovascular Disease  (356)       HTN  (176)       HTN in Youth  (8)       Resident-cell-based  (43)       Subarachnoid Hemorrhage (SAH)  (1)       Transthyretin amyloid cardiomyopathy (ATTR-CM)  (1)    Spontaneous Coronary Artery Dissection (SCAD)  (6)    Stroke  (15)       endovascular thrombectomy  (6)    Vascular Diseases  (21)       mesenteric ischemia  (3) Future Pandemics Inform-graphics  (1) Gastroenterology  (38) Gene Regulation  (233) Gene Regulation and Evolution  (137) Genetics & Innovations in Treatment  (176) Genetics & Pharmaceutical  (204) Genome Biology  (967)    Exosomes  (25)    Gene Therapy & Gene Editing Development  (42)    mRNA Therapeutics  (20)    Mutagenesis  (27)    Single Cell Genomics  (25)    Single-cell sequencing  (20)    Variation in human protein-coding regions  (35) Genomic Endocrinology  (42) Genomic Testing: Methodology for Diagnosis  (416) Genomics Pharmacy  (40) Global Market of Medical Devices Technology  (3) Global Medical Publishers by Country  (3) Global Partnering & Biotech Investment  (48) GLP  (4) Glycobiology: Biopharmaceutical Production  (16) Glycobiology: Biopharmaceutical Production, Pharmacodynamics and Pharmacokinetics  (28) Health Care System by Country  (58)    AI Models in Healthcare  (12)    Centers for Medicare & Medicaid Services  (8)    Health in Israel  (2)    India  (1)    United States  (27)       Hospital-based Medical Innovations  (10)       Medical Recertification and Maintenance of Certification (MOC)  (1) Health Economics and Outcomes Research  (384)    Women Health  (18)       Heart and Brain Disease in Women  (3) Health Law & Patient Safety  (165)    and Bioethics  (14)    Biotechnology  (12)    Health Law Policy  (13) HealthCare IT  (139) Healthcare Reform  (118)    Accountable Care Organizations  (26)    Affordable Care Act  (29)       Repair  (1)       Repeal ACA  (1)       Replace  (1)    Federal Budget Appropriations  (27)    Healthcare costs and reimbursement  (59)    Indigent Nutrition  (14)    Medicare and Medicaid  (20)    Prescription Drugs Costs  (21)    Skilled Nursing Facilities  (6)    Technology Capital Expenses  (15)    Uninsured and Underinsured  (20) Hematology  (100)    Acute lymphocytic leukemia  (18)    Acute myelocytic leukemia  (21)    Hematopoiesis  (48)    Lymphoma  (21) History and physical exam  (6) Human aging  (27) Human Immune System in Health and in Disease  (246) Human Sensation and Cellular Transduction: Physiology and Therapeutics  (21) Image Processing/Computing  (41) Imaging-based Cancer Patient Management  (116) Immuno-Oncology & Genomics  (133)    mRNA platform in Drug DIscovery  (6) Immunodiagnostics  (141)    Cancer-Immune Interactions  (31)    CNS-Immune Interface  (5)    Neuronal Circuits  (4) Immunology  (123)    Adaptive Immune Response to Biomaterials and Tissue Repair  (13)    Antibody Responses Predict Antigen Exposure  (17)    Cytokine Receptor Structure  (8)    Human Antibody Response  (18)    Human Circulating Antibody Repertoire  (11)    Human Naive B Cell Repertoire  (8)    MHC Repertoires for Antigen Prediction  (8)    Protection Against Autoimmune Disease  (11)    Synthetic Immunology: Hacking Immune Cells  (15) Immunotherapy  (136)    CAR-T  (16)    combination immunotherapies.  (15)    Efficacy of Anti-Tumor T Cells  (15)    Engineering Better T Cells  (10)    Immune Engineering  (18)    Immune Modulatory  (16)    Integrin-targeted Combination Immunotherapy  (6)    Modulating Macrophages in Cancer Immunotherapy  (17)    NK Cell-Based Cancer Immunotherapy  (20)    Synergistic Innate and Adaptive Immunotherapy  (14) Income Disparity  (2) Infectious Disease & New Antibiotic Targets  (162)    Antibiotic resistance  (7)    Viral diseases  (37)       Myocarditis  (1) Infectious Disease Immunodiagnostics  (58)    Virology – Vector-borne DIsease  (17) Inflammasome  (29)    Anti-tumor necrosis factor drugs (TNF inhibitors)  (3) Innovation in Immunology Diagnostics  (111)    Universal Immune Cell Therapies (uICT)  (11) Innovations  (186)    R&D Expenditure  (8) Innovations in Neurophysiology & Neuropsychology  (145)    Age and Life Expectancy  (3)    autism spectrum disorder  (1)    Circadian Rhythm and Sleep  (6)    hNPCs  (1)    Nervous System Function  (2)    Relapsing Multiple Sclerosis  (1) Intellectual Property  (85)    Disputes and Settlements  (9)    IP Valuation Models – Pricing Intangible Assets  (7)    Patent Law in Biotech  (12) Intellectual Property, Innovations, Commercialization, Investment in technological breakthrough  (121) International Global Work in Pharmaceutical  (191) Interventional Oncology: Radiofrequency Ablation, Transarterial Chemoembolization, Microwave Ablation and Irreversible Electroporation (IRE)  (12) Interviews with Scientific Leaders  (319)    Albany Medical Center Prize in Medicine and Biomedical Research  (3)    Annual Breakthrough Prize  (4)    Annual Lewis S. Rosenstiel Award  (2)    Awards in Cardiology and Cardiovascular Medicine  (6)    CEOs of Biotech Companies  (3)    Gerald D Aurbach Award for Outstanding Translational Research  (2)    Interviews with Key Opinion Leaders (KOLs)  (11)    James Prize in Science and Technology Integration  (2)    Jessie Stevenson Kovalenko Medal – Medical Sciences  (2)    Lemelson-MIT Prize  (2)    Life Sciences Breakthrough Prize  (6)    Mosteller Statistician of the Year Award  (2)    Mourning the Loss of a Scientific Leader  (6)    National Academy of Sciences AWARDS  (4)    Nobel Prize Winners  (30)    Noble Prize (Not Nobel Prize)  (2)    Paul Marks Prize for Cancer Research  (2)    Russ Prize recognizes bioengineering achievements worldwide  (2)    The Dan David Prize  (6)    Warren Alpert Foundation Prize Recipients  (4)    Wolf Prize  (2)    Wolf Prize in Medicine  (2)    women in science  (5) Investment in Technological Breakthrough  (60) Ionic Transporters Na+  (25) IP Development by LPBI Group Team  (14) IP Development by LPBI Group Team & Other Organizations  (8) ISO 14155  (3) Joint Venture – SBH & M3DP: SOP and Arrangements  (1) Justice & Law  (1) K  (15) Lab-on-a-chip  (2) Landscape  (1) Lasers and photonics  (18)    Midrange IR spectroscopy  (1) Law and Medicine Conflicts  (15) Leadership, Power, Social Interlocking Connections  (13) Lipid metabolism  (109)    Fatty acids  (38)    Lipids  (38)    PCSK9 Inhibitor Therapy  (19) Lipidomics  (11) Liposome  (4) Liver & Digestive Diseases Research  (122) LPBI Group, e-Scientific Media, DFP, R&D-M3DP, R&D-Drug Discovery, US Patents: SOPs and Team Management  (143)    Award Nominations  (5)    BioMed e-Books e-Series by LPBI Group  (9)    Feedback from Investors: LPBI Portfolio of Five Businesses  (2)    LPBI Group Founder – Aviva Lev-Ari  (27)    PhD  (1)    RN  (1) LPBI Management  (23) Massachusetts Academy of Sciences (MAS)    (2) Materials Science & Engineering  (37)    Organic BioElectronics  (2) Math  (13)    Great Discoveries  (7) Mechanical Assist Devices: LVAD  (4) Medical and Population Genetics  (193) Medical Devices R&D Investment  (242)    21st Century Cures Act  (2)    CE Mark & Global Regulatory Affairs: process management and strategic planning – GCP  (14)    Rhythm management device hardware: dual-chamber pacemakers  (1)       Systolic HTN  (1) Medical Imaging Technology  (59) Medical Imaging Technology, Image Processing/Computing, MRI, CT, Nuclear Medicine, Ultra Sound  (164)    Circumferential-Intravascular-Radioluminescence-Photoacoustic-Imaging (CIRPI)  (3)    Echocardiography  (3)    MRI  (18)    Noninvasive Diagnostic Fractional Flow Reserve (FFR) CT  (6)    Ultra Sound  (10) Melatonin & Circadian Regulation  (9) memory loss  (1) Metabolism  (239)    Biochemical pathways  (144)       Enzymes and isoenzymes  (73)          Dehydrogenase  (16)          Kinase  (28)          Phosphatase  (9)          Phosphorylase  (22)          tyrosine decarboxylases  (3)    Inosine nucleotides  (9)    Leloir pathway  (6)    microbiome  (7)    Pentose monophosphate shunt  (14)    Pyridine nucleotides  (28)       Pyridine nucleotide transhydrogenase  (7) Metabolomics  (321) Methods  (37) Mg++  (10) Microbiologial genetics  (36) Microbiology  (68)    Virology  (14) Micronutrients  (16) Microvesicle  (7) Microwave Ablation and Irreversible Electroporation (IRE)  (1) Mobile Healthcare  (5) Molecular Genetics & Pharmaceutical  (377)    Organoids  (3) Monoclonal antibody therapy  (14) Mutant Gene Expression  (42) Myocardial adenine nucleotide metabolism  (6) Myocardial Ischemia  (26) Myocardial Metabolism  (36) Na-K transport  (40) Na-K-ATPase  (27) Nanotechnology for Drug Delivery  (99) Nephrology  (46) Nephrology & Regenerative medicine  (9) Neurodegenerative Diseases  (89)    hNPCs  (3)    MS  (5) Neurohumoral Transmission  (68)    Ca2+ triggered activation  (21)    Calmodulin  (13)    Parkinson’s disease dyskinesia levodopa  (3)    PKC  (13)    Synaptic vesicle  (20) Neurological Diseases  (121) Neuroscience  (126) Next Generation Sequencing (NGS)  (27)    Nanopore sequencing  (1) NIH Common Fund  (1) Nitric Oxide in Health and Disease  (136) Nuclear Medicine  (11) Nutrigenomics  (68) Nutrition  (195)    Nutritional Supplements: Atherogenesis, lipid metabolism  (50) Nutrition and Phytochemistry  (62)    Minerals in Medicine  (4)    Plant extract  (22) Nutrition Disorders  (31) Nutritional Supplements: Atherogenesis  (31) Obesity  (19) Oligonucleotide Therapeutics & Delivery  (7) Oncolytic virus & OncoViro-Therapy  (23)    Synthetic Virology  (1) Organ-on-a-Chip & 3D Printing in Life Sciences  (7) Pain: Etiology, Genetics & Innovations in Treatment  (24) Parasitology  (5)    Malaria  (4)    Tropical diseases  (1) Patents  (35) Patient Experience  (66)    Art therapy  (1)    Hospital reputation  (7)    Humor  (1)    Music therapy  (2)    Pain Alleviation  (7)    Patient Outlook  (28)    Reputation of Interventionist  (4)    Support Staff  (13)    Supportive therapies  (6)       laughfter  (1)    Surgical Procedure  (9) Patient Experience: Personal Memories of Invasive Medical Intervantion  (30) Patient’s Voice: Personal Experience with Invasive Medical Procedures  (18) Perioperative Statins at Noncardiac Surgery  (2) Personal Health Applications: Tech Innovations serves HealhCare  (43) Personalized and Precision Medicine & Genomic Research  (738)    Longevity  (3)    New Drug Approval  (5)    Patient-centered Medicine  (39)       cell-based therapy  (9)       stem cell biology and patient-specific  (7)    Personalized Medicine Coalition  (10)    Precision Cancer Medicine  (33) Phagophore  (2) Pharmaceutical Analytics  (261)    Pharmacologic toxicities  (62) Pharmaceutical Discovery  (111)    Rapid automation of plasma protein pools  (18) Pharmaceutical Drug Discovery  (205)    Drug Development Process  (60)       Drug Discovery Chemistry  (33)    drug repurposing  (11) Pharmaceutical Industry Competitive Intelligence  (346)    Pharmacovigilance  (7)    Value-based Drug Pricing  (8) Pharmaceutical R&D Informatics  (45) Pharmaceutical R&D Investment  (301) Pharmacodynamics and Pharmacokinetics  (24) Pharmacogenomics  (161) Photography Collection  (1) Physics  (12) Placenta  (7) Population genetics  (27) Population Health Management  (205)    Evolution of Biology Through Culture  (14)    U.S. Employment-to-Population Ratio  (8) Population Health Management, Genetics & Pharmaceutical  (643)    COVID-19  (157)       Biomarkers: Inflammation  (37)       Cancer Researchers Fighting COVID-19  (14)       COVID-19 effects on Human Heart  (15)       COVID-19: Pandemic Surgery Guidance  (19)       Economic Impact of Coronavirus Pandemic  (41)       number of asymptomatic infections  (27)       Treatment Protocols for COVID-19  (62)    SARS-CoV-2  (141)       Coronavirus Gene Expression  (66)          SARS-CoV-2 circulating variants   (14)          SARS-CoV-2 Viral Variants  (19)       Glycosylation and its Role in SARS-CoV-2 Viral Pathogenesis  (2)       Immune-Mediation (independent immunopathology: lung and reticuloendothelial system)  (30)       Mechanisms of infection by SARS-CoV-2  (21)       SAR-Cov-2 a vasculotropic (blood vessels) RNA Virus  (35)          SARS-COV2 Hijacking the Complement and Coagulation Systems  (19)       Seasonality & Environmental Factors in Resurgence  (26)       Serology tests for coronavirus antibodies  (44)       T-cell response to SARS-CoV-2 infection  (14)       Vaccinology  (51)          Mechanism of Thrombosis with AZ & J&J COVID-19 Vaccines  (5)       Virtual Drug Molecule Screening targeting SAR-CoV-2 proteins  (8)    Virus Infective Acute Respiratory Syndrome: SARS-CoV  (92) Population Health Management, Nutrition and Phytochemistry  (162) Preimplantation Genetic Diagnosis and Reproductive Genomics  (13) Protein-energy malnutrition  (12) Proteomics  (367)    Amino acids  (54)    Proteins  (138) Pulmonary diseases  (16)    Lung and pulmonology  (15) Pulmonary pathology  (8) Radio Frequency (RF)-based Surgical Solutions  (2) REAL TIME Conference Coverage Twitter’s Hashtags and Handles per Presentation/session  (50) Regenerative Biology and Medicine  (92) Regulated Clinical Trials: Design, Methods, Components and IRB related issues  (265) Reproductive Andrology, Embryology, Genomic Endocrinology, Preimplantation Genetic Diagnosis and Reproductive Genomics  (113) Reproductive Biology & Bio Instrumentation  (78) RNA Biology  (81)    RNA interference (RNAi) therapeutic  (4) RNA Biology, Cancer and Therapeutics  (64) RVAD  (1) SBIR, SBA, NIH, NSF  (3) Schizophrenia  (16) Scientific & Biotech Conferences: Press Coverage  (182) Scientific Publishing  (609)    Curation  (585)       Curation methodology  (40)       De novo synthesis  (16)       Dialectic  (17)       Discovery process  (72)       Evolutionary cognition  (52)       Experimental validation  (91)       Explanatory  (91)       Historical relevance  (71)       Technology Advance Assessment of  (69)       Theoretic convergence  (27)    Open Access Journals  (37) Scientist: Career considerations  (198)    Big Data & Analytics  (17)    Data Science  (13)    Women in Life Sciences  (12) Scoop.it  (19) Sensors & Analytics  (18) Sepsis  (2) Severe Autism  (3) Signaling  (102)    Phosphorylation  (43)    S-nitrosylation  (13)    Ubiquitinylation  (34) Signaling & Cell Circuits  (130) single cell sequencing  (3) Small Molecules in Development of Therapeutic Drugs  (71) Social Development  (15) Specialized 3D BioPrinters (Cornea  (1) Statistical Methods for Research Evaluation  (137) Stem Cells for Regenerative Medicine  (177)    Cardiac muscle regeneration  (19)    Competition in regenerative stem cell science  (18)    Human neural progenitor cells  (8)    Skeletal muscle regeneration  (9) STORM  (2) Stress Disorders  (19) Substance Abuse  (4) Systemic Inflammatory Response Related Disorders  (161)    Inflammatory Pathophysiology  (9) Technology Transfer: Biotech and Pharmaceutical  (354) therapeutics  (3) Tissue Engineering and Regenerative Medicine  (22) Tissue Microenvironment  (5) Transarterial Chemoembolization  (2) Transcriptomics  (47) Transformative Technologies in Healthcare  (23) Translational Science  (230)    Best evidence  (52)    Bias measurement tools  (2)    Evidence-based decision-making  (29)    Inferential analysis  (25)    Intra-rater error  (1)    Quality Assurance  (8)    Random Error  (2)    Systematic Error (Bias)  (6)    Total error  (2)    Translational Effectiveness  (49)    Translational Research  (92) Trends in Global Economy  (6) Uncategorized  (1,019) Unfolded Protein Response (UPR)  (6) US and Global Economy: Trends and Findings  (9) Venture Capital  (47)    Income Geographic Distribution  (3)    Institutional Capital Raised by Female Founders  (6) virology  (10) Vision  (7) Voices of Patients and Healthcare Providers  (22) Water Transporters  (8) Wearable Tech + Digital Health  (5) Anemia  (22) Neutropenia  (8) Neutrophilia  (9) Platelet count disorder  (9) Folate and B12  (7) Iron deficiency  (5) Myelodysplasia  (13) Myelofibrosis  (10)

• Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

• • 2012pharmaceutical
  • sjwilliamspa